Jazz Pharmaceuticals plc
JAZZ
$125.22
-$0.94-0.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -404.84M | 482.20M | 560.12M | 463.16M | 394.92M |
| Total Depreciation and Amortization | 672.53M | 661.56M | 660.07M | 650.85M | 648.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.19B | 259.93M | 252.44M | 228.45M | 205.98M |
| Change in Net Operating Assets | -145.53M | 154.78M | -76.72M | -177.80M | -175.96M |
| Cash from Operations | 1.32B | 1.56B | 1.40B | 1.16B | 1.07B |
| Capital Expenditure | -50.92M | -45.05M | -38.07M | -34.89M | -28.40M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -858.05M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 119.83M | -360.18M | -470.13M | -178.23M | -573.10M |
| Cash from Investing | -789.15M | -405.22M | -508.20M | -213.11M | -601.50M |
| Total Debt Issued | 980.77M | 980.77M | 980.77M | 980.77M | -- |
| Total Debt Repaid | -1.36B | -1.36B | -606.00M | -606.00M | -31.00M |
| Issuance of Common Stock | 31.16M | 31.60M | 20.65M | 20.30M | 25.80M |
| Repurchase of Common Stock | -350.05M | -387.05M | -369.18M | -466.59M | -391.24M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.72M | -5.72M | -5.72M | -- | -- |
| Cash from Financing | -699.84M | -736.40M | 20.52M | -71.52M | -396.44M |
| Foreign Exchange rate Adjustments | 7.10M | 1.72M | -1.68M | 2.40M | -1.69M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -165.92M | 418.56M | 906.55M | 882.45M | 73.50M |